drugset / Trial / NCT05322148
Cyclosporine 0.1% / Loteprednol 0.2% Effect on Anterior Segment Normalization
RandomizedParallel-groupOpen-labelTreatment
Summary
The CLEAN Study: Cyclosporine 0.1% / Loteprednol 0.2% Effect on Anterior Segment Normalization-A Prospective Cohort Study of Combination Therapy in the Treatment of Dry Eye
Timeline
- Start
- 2022-06-03
- Primary completion
- 2022-11-17
- Completion
- 2022-11-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cyclosporine | Peptide | 0.05 % | — |
| Comparator | Cyclosporine | Peptide | 0.1 % | — |
| Comparator | Loteprednol Etabonate | Other / unclassified | 0.2 % | — |